Kate Kernan

Dr. Kate Kernan

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Blood
Verified
Journal Article
Open access
PDF file
JHJan-Inge Henter
Jan-Inge Henter
ESElena Sieni
Elena Sieni
JEJulia Eriksson
Julia Eriksson
EBElisabet Bergsten
Elisabet Bergsten
IMIda Hed Myrberg
Ida Hed Myrberg
MJMichael B. Jordan
Michael B. Jordan
Current hemophagocytic lymphohistiocytosis 2004 (HLH-2004)–based diagnostic criteria for familial hemophagocytic lymphohistiocytosis (FHL) are based on expert opinion. Here, we performed a case-control study to test and possibly improve these criteria. We also developed 2 complementary expert opinion–based diagnostic strategies for FHL in patients with signs/symptoms suggestive of HLH, based on genetic and cellular cytotoxicity assays. The cases (N = 366) were children aged <16 years with verified familial and/or genetic FHL (n = 341) or Griscelli syndrome type 2 (n = 25); 276 from the HLH-94/HLH-2004 databases and 90 from the Italian HLH Registry. All fulfilled the HLH-94/HLH-2004 patient inclusion criteria. Controls were 374 children with systemic-onset juvenile idiopathic arthritis (sJIA) and 329 + 361 children in 2 cohorts with febrile infections that could be confused with HLH and sepsis, respectively. To provide complete data sets, multiple imputations were performed. The optimal model, based on 17 variables studied, revealed almost similar diagnostic thresholds as the existing criteria, with accuracy 99.1% (sensitivity 97.1%; specificity 99.5%); the original HLH-2004 criteria had accuracy 97.4% (sensitivity 99.0%; specificity 97.1%). Because cellular cytotoxicity assays here constitute a separate diagnostic strategy, HLH-2004 criteria without natural killer (NK)–cell function was also studied, which showed accuracy 99.0% (sensitivity, 96.2%; specificity, 99.5%). Thus, we conclude that the HLH-2004 criteria (without NK-cell function) have significant validity in their current form when tested against severe infections or sJIA. It is important to exclude underlying malignancies and atypical infections. In addition, complementary cellular and genetic diagnostic guidelines can facilitate necessary confirmation of clinical diagnosis.

6 July 2018 in Genes & Immunity
Verified
Journal Article
Closed access
PDF file
KKKate Kernan
Kate Kernan
LGLina Ghaloul-Gonzalez
Lina Ghaloul-Gonzalez
BSBita Shakoory
Bita Shakoory
JKJohn A. Kellum
John A. Kellum
DADerek C. Angus
Derek C. Angus
JCJoseph A. Carcillo
Joseph A. Carcillo

1 January 2022 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
KKKate Kernan
Kate Kernan
LGLina Ghaloul-Gonzalez
Lina Ghaloul-Gonzalez
JVJerry Vockley
Jerry Vockley
JLJanette Lamb
Janette Lamb
DHDeborah Hollingshead
Deborah Hollingshead
JCJoseph A. Carcillo
Joseph A. Carcillo
: Purpose: Our understanding of inborn errors of immunity is increasing; however, their contribution to pediatric sepsis is unknown. Methods: We used whole-exome sequencing (WES) to characterize variants in genes related to monogenic immunologic disorders in 330 children admitted to intensive care for severe sepsis. We defined candidate variants as rare variants classified as pathogenic or potentially pathogenic in QIAGEN’s Human Gene Mutation Database or novel null variants in a disease-consistent inheritance pattern. We investigated variant correlation with infection and inflammatory phenotype. Results: More than one in two children overall and three of four African American children had immunodeficiency-associated variants. Children with variants had increased odds of isolating a blood or urinary pathogen (blood: OR 2.82, 95% CI: 1.12–7.10, p = 0.023, urine: OR: 8.23, 95% CI: 1.06–64.11, p = 0.016) and demonstrating increased inflammation with hyperferritinemia (ferritin $$\ge 500$$ ≥ 500 ng/mL, OR: 2.16, 95% CI: 1.28–3.66, p = 0.004), lymphopenia (lymphocyte count < 1000/µL, OR: 1.66, 95% CI: 1.06 – 2.60, p = 0.027), thrombocytopenia (platelet count < 150,000/µL, OR: 1.76, 95% CI: 1.12–2.76, p = 0.013), and CRP greater than 10 mg/dl (OR: 1.71, 95% CI: 1.10–2.68, p = 0.017). They also had increased odds of requiring extracorporeal membrane oxygenation (ECMO, OR: 4.19, 95% CI: 1.21–14.5, p = 0.019). Conclusion: Herein, we describe the genetic findings in this severe pediatric sepsis cohort and their microbiologic and immunologic significance, providing evidence for the phenotypic effect of these variants and rationale for screening children with life-threatening infections for potential inborn errors of immunity.

3 July 2023 in GigaScience
Verified
Journal Article
Open access
PDF file
ZFZhenjiang Fan
Zhenjiang Fan
KKKate Kernan
Kate Kernan
ASAditya Sriram
Aditya Sriram
PBPanayiotis V Benos
Panayiotis V Benos
SCScott W Canna
Scott W Canna
HPHyun Jung Park
Hyun Jung Park
Background: Learning the causal structure helps identify risk factors, disease mechanisms, and candidate therapeutics for complex diseases. However, although complex biological systems are characterized by nonlinear associations, existing bioinformatic methods of causal inference cannot identify the nonlinear relationships and estimate their effect size. Results: To overcome these limitations, we developed the first computational method that explicitly learns nonlinear causal relations and estimates the effect size using a deep neural network approach coupled with the knockoff framework, named causal directed acyclic graphs using deep learning variable selection (DAG-deepVASE). Using simulation data of diverse scenarios and identifying known and novel causal relations in molecular and clinical data of various diseases, we demonstrated that DAG-deepVASE consistently outperforms existing methods in identifying true and known causal relations. In the analyses, we also illustrate how identifying nonlinear causal relations and estimating their effect size help understand the complex disease pathobiology, which is not possible using other methods. Conclusions: With these advantages, the application of DAG-deepVASE can help identify driver genes and therapeutic agents in biomedical studies and clinical trials.

22 May 2025 in EULAR Rheumatology Open
Verified
Journal Article
Open access
DPDimitri Poddighe
Dimitri Poddighe
BSBita Shakoory
Bita Shakoory
AGAshley V. Geerlinks
Ashley V. Geerlinks
MWMarta Wilejto
Marta Wilejto
KKKate Kernan
Kate Kernan
EDErkan Demirkaya
Erkan Demirkaya

16 June 2025 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
KKKate Kernan
Kate Kernan
MSMohammed Shaik
Mohammed Shaik
CHChristopher M. Horvat
Christopher M. Horvat
DFDana Y. Fuhrman
Dana Y. Fuhrman
ZAZachary Aldewereld
Zachary Aldewereld
RARajesh K. Aneja
Rajesh K. Aneja
Introduction: In 2024, a Society of Critical Care Medicine task force updated the pediatric sepsis definition from the presence of suspected or confirmed infection, and a systemic inflammatory response (SIRS) with organ dysfunction, to a novel definition. Our objective is to identify how many patients previously identified as having severe sepsis would continue to meet the new definition. Materials and methods: We performed a secondary analysis of the Phenotyping Sepsis-Induced Multiple Organ Failure cohort of 401 children with suspected or confirmed infection, two of four SIRS criteria and organ dysfunction enrolled between 2015-2017. We calculated a modified Phoenix Sepsis Criteria Score (mPSC) for participants and compared those with mPSC of greater than or equal to 2 or less than 2 according to the 2024 definition. Results: Of 401 children, 132 (33%) did not meet mPSC definitions. While children meeting mPSC had more organ dysfunction, the total mortality did not differ. One in 4 children requiring extracorporeal membrane oxygenation and 1 in 4 mortalities did not meet the mPSC definition. In logistic regression models, in the complete cohort, hematologic (OR 4.4, 95% CI: 1.8-10.2, P -value = .001), central nervous system (OR 2.3, 95% CI: 1.0-5.1, P -value = .046) and renal failure (OR: 3.2, 95% CI:1.2-7.9, P -value = .017) predicted mortality; in the mPSC subgroup pulmonary (OR: 3.6, 95% CI:1.3-13.3, P -value = .030) and hematologic failure (OR 5.6, 95% CI: 2.2-14.5, P -value = .0003) were significant predictors. In the mPSC excluded subgroup, only renal failure predicted mortality (OR 9.6, 95% CI 1.1-73.0, P -value = .028). Conclusions: Further study of the impact of the 2024 data-driven organ dysfunction definition on pediatric sepsis research, patient safety, and clinical benchmarking efforts is warranted.